Tower Research Capital LLC (TRC) - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 68 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$20,918
+326.5%
17,879
+359.3%
0.00%
Q1 2024$4,905
-76.9%
3,893
-67.4%
0.00%
Q4 2023$21,239
+89.5%
11,932
+76.7%
0.00%
Q3 2023$11,210
+116.2%
6,753
+160.5%
0.00%
Q2 2023$5,184
+172700.0%
2,592
+61.8%
0.00%
Q1 2023$3
-100.0%
1,602
-75.2%
0.00%
Q1 2022$7,0006,465
+8879.2%
0.00%
Q4 2021$0
-100.0%
72
-98.5%
0.00%
Q2 2021$9,000
+80.0%
4,658
+328.1%
0.00%
Q1 2021$5,0001,0880.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 62,234$72,8140.06%
Orin Green Financial, LLC 72,000$84,2400.04%
GSA CAPITAL PARTNERS LLP 401,244$4690.03%
Point72 Asia (Singapore) Pte. Ltd. 68,163$79,7510.02%
CAPITAL PERFORMANCE ADVISORS LLP 26,793$31,3480.01%
Y-Intercept (Hong Kong) Ltd 158,259$185,1630.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,790$215,0340.01%
HARBOUR INVESTMENT MANAGEMENT LLC 10,100$11,8170.01%
MIRABELLA FINANCIAL SERVICES LLP 30,000$35,1000.00%
Centiva Capital, LP 130,332$152,4880.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders